SEHK:6181
SEHK:6181Luxury

Laopu Gold (SEHK:6181): Assessing Valuation Following Board Approval of Dividend and Governance Changes

Laopu Gold (SEHK:6181) announced two key moves at its recent EGM. The company approved an interim dividend and amendments to its Articles of Association. Both steps signal immediate implications for current shareholders. See our latest analysis for Laopu Gold. Laopu Gold’s recent board decisions seem to have reignited interest, as reflected in its remarkable year-to-date share price return of 142.62% and a one-year total shareholder return of 225.6%. While momentum has cooled a bit in the...
SEHK:345
SEHK:345Food

Vitasoy (SEHK:345) Net Margin Jumps to 3.9%, Reinforcing Optimistic Profitability Narratives

Vitasoy International Holdings (SEHK:345) has just released its H1 2026 earnings, reporting revenue of $6.1 billion HKD and basic EPS of 0.22 HKD for the trailing twelve months, while net income came in at 236 million HKD. Looking back, the company has seen revenue hold steady over recent periods, with $6.3 billion HKD in H2 2025 and $6.3 billion HKD in H1 2025. EPS moved from 0.22 HKD to 0.12 HKD through these intervals. Margins have become a bigger part of the story for investors, with...
SEHK:1929
SEHK:1929Specialty Retail

Chow Tai Fook (SEHK:1929) Net Margin Rises to 6.6%, Challenging Cautious Profitability Narratives

Chow Tai Fook Jewellery Group (SEHK:1929) just released its H1 2026 results, posting revenue of HK$39.0 billion and basic EPS of HK$0.26, with net income at HK$2.5 billion. Looking back, the company has seen revenue move from HK$39.4 billion in H1 2025 to HK$50.2 billion in H2 2025 before the latest tally. EPS shifted from HK$0.25 to HK$0.34 and then HK$0.26. Margins held up as investors focus on how recent profit improvements fit into the wider story. See our full analysis for Chow Tai Fook...
SEHK:388
SEHK:388Capital Markets

Hong Kong Exchange (SEHK:388): Evaluating Valuation After Recent Cool-Off in Share Price Momentum

Hong Kong Exchanges and Clearing (SEHK:388) shares have drawn investor attention following their recent price moves. Given the platform’s central role in Asia’s financial markets, these fluctuations are often viewed in relation to broader market trends. See our latest analysis for Hong Kong Exchanges and Clearing. After a remarkable rally earlier in the year, Hong Kong Exchanges and Clearing’s share price has cooled recently, with a 4.8% decline over the past month and a slight dip in the...
SEHK:780
SEHK:780Hospitality

Tongcheng Travel (SEHK:780) Net Profit Margin Improves to 14%, Reinforcing Bullish Narratives

Tongcheng Travel Holdings (SEHK:780) just released Q3 2025 numbers, posting revenue of ¥5.5 billion and basic EPS of ¥0.42. The company has seen revenue rise from ¥4.2 billion in Q4 2024 to ¥5.5 billion this quarter, while EPS climbed from ¥0.15 to ¥0.42 over the same period. With margins holding firm and net profitability expanding, investors have clear figures to ground the latest story around the business. See our full analysis for Tongcheng Travel Holdings. Now, we are putting those...
SEHK:6855
SEHK:6855Biotechs

Assessing Ascentage Pharma (SEHK:6855) Valuation Following Major Data Publication on Olverembatinib in Rare GIST Subtype

Ascentage Pharma Group International (SEHK:6855) garnered investor interest after publishing new data from a Phase Ib study for its drug olverembatinib in patients with SDH-deficient gastrointestinal stromal tumors. See our latest analysis for Ascentage Pharma Group International. Following the announcement of encouraging new results for olverembatinib, Ascentage Pharma Group International has continued to capture investor attention, even as its share price has pulled back 6.4% over the past...
SEHK:1757
SEHK:1757Construction

Affluent Foundation (SEHK:1757): Net Profit Margin Falls to 0.3%, Challenging Bullish Narratives

Affluent Foundation Holdings (SEHK:1757) just released its H1 2026 results, posting total revenue of $115.3 million HKD and basic EPS of 0.000799 HKD. Looking back, the company saw revenue trend from $70.4 million HKD in H2 2024 to $125.4 million HKD in H1 2025, before landing at $115.3 million HKD in this latest update. EPS moved from 0.001429 HKD to 7.8e-05 HKD during the same periods. Margins were tight across these results, with profitability metrics flashing a caution light for investors...
SEHK:1499
SEHK:1499Construction

OKG Technology (SEHK:1499) Margin Stagnation Reinforces Investor Concerns Despite H1 2026 Revenue Growth

OKG Technology Holdings (SEHK:1499) has just reported its H1 2026 results, with total revenue at 340.9 million HKD and a basic EPS of -0.001994 HKD. The numbers reflect a continuation of unprofitable results for the company. Revenue has grown from 195.7 million HKD in H1 2025 and 123.5 million HKD in H1 2024. Investors will be closely watching margins as profit trends remain negative. See our full analysis for OKG Technology Holdings. Next up, we’ll see how these results measure up against...
SEHK:9969
SEHK:9969Biotechs

InnoCare Pharma (SEHK:9969) Valuation in Focus After Revenue Growth and Narrowed Losses

InnoCare Pharma (SEHK:9969) just released its latest earnings, reporting both higher revenue and a significantly smaller net loss for the nine months through September. These results are giving investors plenty to analyze right now. See our latest analysis for InnoCare Pharma. Fresh from reporting sharply reduced net losses and steadily rising revenue, InnoCare Pharma has enjoyed some serious momentum. Its share price has soared 160.98% year-to-date, and over the past year, investors have...
SEHK:1050
SEHK:1050Electronic

Asian Market Insights: 3 Penny Stocks With Market Caps Over US$20M

Amidst global concerns about AI valuations and economic uncertainties, Asian markets have mirrored some of the cautious sentiment seen in other regions. For investors interested in exploring smaller or newer companies, penny stocks continue to present intriguing opportunities despite their somewhat dated terminology. These stocks, often representing under-the-radar growth potential at lower price points, can offer significant upside when backed by strong financial health and solid fundamentals.
SEHK:981
SEHK:981Semiconductor

A Fresh Look at SMIC (SEHK:981) Valuation Following Higher Sales and Upbeat Q4 Guidance

Semiconductor Manufacturing International (SEHK:981) just released its latest earnings, showing increased sales and net income for the nine months ending September 30, 2025. The company also projected stable or slightly higher revenue for the upcoming quarter. See our latest analysis for Semiconductor Manufacturing International. On the heels of stronger sales and upbeat guidance, Semiconductor Manufacturing International’s 1-year total shareholder return stands out at 167.9%, showing...
SEHK:270
SEHK:270Water Utilities

Guangdong Investment (SEHK:270): Reviewing Valuation After Securing HKD 2.25 Billion Debt Facility

Guangdong Investment (SEHK:270) revealed acceptance of a HKD 2.25 billion committed term loan facility on 19 November 2025. The loan is aimed at funding general corporate needs and refinancing existing debt, subject to specific ownership-related covenants. See our latest analysis for Guangdong Investment. The new loan announcement comes as Guangdong Investment’s share price has steadily gained traction this year, climbing 14.8% year-to-date, with the latest move up to HK$7.59. Momentum has...